CME Group Inc. (CME) Reaches New 12-Month High at $142.33
CME Group Inc. (NASDAQ:CME)’s share price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $142.33 and last traded at $139.49, with a volume of 924300 shares traded. The stock had previously closed at $140.09.
Several research firms have recently issued reports on CME. Barclays PLC lifted their price target on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 10th. Wells Fargo & Company lifted their price objective on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. Royal Bank Of Canada lifted their price objective on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. Citigroup Inc. lifted their price objective on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, BidaskClub downgraded CME Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the stock. CME Group presently has an average rating of “Buy” and an average target price of $141.75.
The firm has a market capitalization of $48,120.41, a P/E ratio of 29.69, a PEG ratio of 2.91 and a beta of 0.71. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same period in the previous year, the firm earned $1.05 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. equities analysts predict that CME Group Inc. will post 4.78 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 dividend on an annualized basis and a yield of 1.85%. CME Group’s dividend payout ratio is presently 59.86%.
In other news, CFO John W. Pietrowicz sold 5,175 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total transaction of $722,947.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 2,600 shares of the company’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $139.57, for a total value of $362,882.00. Following the sale, the insider now directly owns 22,301 shares in the company, valued at $3,112,550.57. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,939 shares of company stock worth $1,910,968. 0.57% of the stock is owned by insiders.
Several institutional investors and hedge funds have recently modified their holdings of the company. Fiduciary Trust Co. purchased a new stake in CME Group during the 2nd quarter valued at $105,000. Quadrant Capital Group LLC raised its holdings in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after buying an additional 113 shares during the period. Valeo Financial Advisors LLC purchased a new stake in CME Group during the 3rd quarter valued at $124,000. San Francisco Sentry Investment Group CA purchased a new stake in CME Group during the 2nd quarter valued at $129,000. Finally, Whittier Trust Co. raised its holdings in CME Group by 2.6% during the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after buying an additional 27 shares during the period. 82.58% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.watchlistnews.com/cme-group-inc-cme-reaches-new-12-month-high-at-142-33/1718887.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.